Showing results (681-690 of 9,056) with videos related to
Sort By:
Pageof 906
Rheumatology (Oxford, England)|June 5, 2003
Acupuncture to reduce nausea during chemotherapy treatment of rheumatic diseasesA Josefson, M KreuterRheumatology (Oxford, England)|June 5, 2003
Osmic acid revisited: factors that predict a favourable responseR Bessant, A Steuer, S Rigby, et al.Rheumatology (Oxford, England)|June 18, 2003
Ciprofloxacin reduces the stimulation of prostaglandin E(2) output by interleukin-1beta in human tendon-derived cellsA N Corps, V A Curry, R L Harrall, et al.Rheumatology (Oxford, England)|February 14, 2004
Maintenance of remission with leflunomide in Wegener's granulomatosisC Metzler, C Fink, P Lamprecht, et al.Rheumatology (Oxford, England)|February 14, 2004
Are evidence-based guidelines being followed for the monitoring of ocular toxicity of hydroxychloroquine? A nationwide survey of practice amongst consultant rheumatologists and implications for clinical governanceA Samanta, L Goh, A BawendiRheumatology (Oxford, England)|February 14, 2004
Systemic lupus erythematosus and gouty arthritis: an uncommon associationS Bajaj, B J Fessler, G S AlarcónRheumatology (Oxford, England)|October 21, 2003
Relevance of thiopurine methyltransferase status in rheumatology patients receiving azathioprineG P R Clunie, L LennardRheumatology (Oxford, England)|October 21, 2003
Post-onset inhibition of murine arthritis using combined chemokine antagonist therapyJ-H Gong, R Yan, J D Waterfield, et al.Rheumatology (Oxford, England)|October 31, 2003
Measuring dyspepsia-related health in randomized trials: the Severity of Dyspepsia Assessment (SODA) and its use in treatment with NSAIDs and COX-2-specific inhibitorsL RabeneckRheumatology (Oxford, England)|October 31, 2003
The burden of acute postoperative pain and the potential role of the COX-2-specific inhibitorsJ Stephens, B Laskin, C Pashos, et al.Pageof 906